JAMA Oncology

Published by: American Medical Association  

People

  1. Aghajanian
    Aghajanian
  2. Friedman
    Friedman
  3. Donoghue
    Donoghue
  4. Offit
    Offit
  5. Panageas
    Panageas
  6. Postow
    Postow
  7. Robson
    Robson
  8. Schram
    Schram
  9. Shoushtari
    Shoushtari
  10. Abu-Rustum
    Abu-Rustum

Groups

  1. Department of Medicine (13)
  2. Gynecologic Medicine Service (13)
  3. Solid Tumor Oncology Division (13)
  4. GDMT, Medicine (9)
  5. Gynecology Disease Management Team (9)
  6. Weinberg Fellows (6)
  7. Epidemiology and Biostatistics (5)
  8. Population Sciences Research Program (5)
  9. Biostatistics Service (4)
  10. GSK Faculty (4)
Search Within
  1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (11)
  2. Guidelines (1)
  3. Research Letter (1)
Groups
  1. Department of Medicine (13)
  2. Gynecologic Medicine Service (13)
  3. Solid Tumor Oncology Division (13)
  4. GDMT, Medicine (9)
  5. Gynecology Disease Management Team (9)
  6. Weinberg Fellows (6)

More Groups

People
  1. Carol Aghajanian (5)
  2. Claire Friedman (3)
  3. Alexander Shoushtari (2)
  4. Alison Schram (2)
  5. Angela Arnold (2)
  6. Katherine Panageas (2)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publishers
  1. American Medical Association (13)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing for HLA genotype screening and matching to HLA-restricted therapies
    Research Letter

    Gormally, M. V.; Chen, M. F.; Noronha, A. M.; Panageas, K.; Reynolds, M.; Kohlasch, K.; Novak, B.; Kee-Velez, T.; Clarke, N.; Eubank, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Avelumab plus talazoparib in patients with advanced solid tumors: The JAVELIN PARP Medley nonrandomized controlled trial
    Journal Article

    Yap, T. A.; Bardia, A.; Dvorkin, M.; Galsky, M. D.; Beck, J. T.; Wise, D. R.; Karyakin, O.; Rubovszky, G.; Kislov, N.; Rohrberg, K.; more...
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Avelumab plus talazoparib in patients with BRCA1/2- or ATM-altered advanced solid tumors: Results from JAVELIN BRCA/ATM, an open-label, multicenter, phase 2b, tumor-agnostic trial
    Journal Article

    Schram, A. M.; Colombo, N.; Arrowsmith, E.; Narayan, V.; Yonemori, K.; Scambia, G.; Zelnak, A.; Bauer, T. M.; Jin, N.; Ulahannan, S. V.; more...
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Clinical trial participation among older adult Medicare fee-for-service beneficiaries with cancer
    Journal Article

    Green, A. K.; Tabatabai, S. M.; Aghajanian, C.; Landgren, O.; Riely, G. J.; Sabbatini, P.; Bach, P. B.; Begg, C. B.; Lipitz-Snyderman, A.; Mailankody, S.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Preexisting TP53-variant clonal hematopoiesis and risk of secondary myeloid neoplasms in patients with high-grade ovarian cancer treated with rucaparib
    Journal Article

    Kwan, T. T.; Oza, A. M.; Tinker, A. V.; Ray-Coquard, I.; Oaknin, A.; Aghajanian, C.; Lorusso, D.; Colombo, N.; Dean, A.; Weberpals, J.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Individualizing surveillance mammography for older patients after treatment for early-stage breast cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology consensus statement
    Guidelines

    Freedman, R. A.; Minami, C. A.; Winer, E. P.; Morrow, M.; Smith, A. K.; Walter, L. C.; Sedrak, M. S.; Gagnon, H.; Perilla-Glen, A.; Wildiers, H.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Sequential ipilimumab after chemoradiotherapy in curative-intent treatment of patients with node-positive cervical cancer
    Journal Article

    Mayadev, J. S.; Enserro, D.; Lin, Y. G.; Da Silva, D. M.; Lankes, H. A.; Aghajanian, C.; Ghamande, S.; Moore, K. N.; Kennedy, V. A.; Fracasso, P. M.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Alisertib in combination with weekly paclitaxel in patients with advanced breast cancer or recurrent ovarian cancer: A randomized clinical trial
    Journal Article

    Falchook, G.; Coleman, R. L.; Roszak, A.; Behbakht, K.; Matulonis, U.; Ray-Coquard, I.; Sawrycki, P.; Duska, L. R.; Tew, W.; Ghamande, S.; more...
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma
    Journal Article

    Carlo, M. I.; Mukherjee, S.; Mandelker, D.; Vijai, J.; Kemel, Y.; Zhang, L.; Knezevic, A.; Patil, S.; Ceyhan-Birsoy, O.; Huang, K. C.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Paclitaxel with and without pazopanib for persistent or recurrent ovarian cancer: A randomized clinical trial
    Journal Article

    Richardson, D. L.; Sill, M. W.; Coleman, R. L.; Sood, A. K.; Pearl, M. L.; Kehoe, S. M.; Carney, M. E.; Hanjani, P.; Van Le, L.; Zhou, X. C.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save

    • JAMA Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JAMA Oncology 2374-2437 American Medical Association
    JAMA oncology 23742445 Unknown
    Jama Oncology 2374-2437 American Medical Association
    JAMA Oncology 2374-2445 American Medical Association
    JAMA Oncology 23742437 Unknown
    JAMA Oncology 2374-2437 American Medical Association
    JAMA Oncology 2374-2445 American Medical Association
    JAMA Oncology 2374-2437 American Medical Association
    JAMA Oncology 2374-2445 American Medical Association
    JAMA Oncology 23742437 American Medical Association
    Unknown (2374-2437) 2374-2437 Unknown
    Unknown (2374-2437) 2374-2437 American Medical Association